ProQR Therapeutics N.V. (NASDAQ: PRQR)
$1.87
+0.1200 ( +6.86% ) 121.2K
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.
Market Data
Open
$1.87
Previous close
$1.75
Volume
121.2K
Market cap
$153.53M
Day range
$1.77 - $1.91
52 week range
$1.11 - $3.29
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Quarterly Reports | 4 | Dec 08, 2023 |
| 6-k | Quarterly Reports | 69 | Nov 07, 2023 |
| 6-k | Quarterly Reports | 2 | Sep 27, 2023 |
| 6-k | Quarterly Reports | 67 | Aug 03, 2023 |
| 6-k | Quarterly Reports | 2 | Aug 01, 2023 |